Vivanza biosciences Limited has notified BSE Limited about its non-applicability for submitting the Annual Secretarial Compliance Report for the financial year ended March 31, 2026, under SEBI Regulation 24A. The company cited regulatory exemptions available to smaller listed entities under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Framework and Exemption Criteria

Under Regulation 24A of SEBI (LODR) Regulations, 2018, and circular CIR/CFD/CMD1/27/2019 dated February 8, 2019, listed companies are required to submit an Annual Secretarial Compliance Report prepared by a Company Secretary in Practice. This report covers compliance with all applicable SEBI regulations and circulars, and must be submitted to stock exchanges within 60 days from the financial year end.

However, Regulation 15(2) of SEBI (LODR) Regulations, 2015, provides exemptions from corporate governance provisions, including Regulation 24A, for specific categories of listed entities.

Company's Financial Position and Exemption Status

Vivanza Biosciences qualifies for exemption under the criteria for listed entities with specific financial thresholds:

The exemption applies to listed entities meeting either of two conditions:

• Paid-up equity share capital not exceeding Rs. 10 crores and net worth not exceeding Rs. 25 crores as on the last day of the previous financial year
• Entities whose specified securities are listed on SME Exchange

Compliance Communication

In its communication dated April 15, 2026, to BSE's Corporate Relationship Department, the company formally declared its exemption status. Company Secretary and Compliance Officer Chaitra Arora signed the notification, confirming that the provisions of Regulation 24A do not apply to the company based on its financial position.

The communication emphasizes that since Vivanza Biosciences falls under the exempted category, it is not required to submit the Annual Secretarial Compliance Report as mandated under Regulation 24A of the SEBI (LODR) Regulations, 2015. The company has requested BSE to acknowledge and take this information on record.

Vivanza Biosciences Limited has filed a non-applicability statement with BSE Limited regarding compliance requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that it has not undertaken any fund-raising activities that would necessitate filing a deviation statement.

Regulatory Compliance Communication

The communication, dated 14th April, 2026, was addressed to the Department of Corporate Services at BSE Limited. The statement pertains to Regulation 32 of SEBI LODR Regulations, which requires companies to submit statements regarding any deviations or variations from the proceeds of various fund-raising activities.

Fund Raising Activities Status

Vivanza Biosciences confirmed that the company has not raised any funds through the following methods:

• Public Issue
• Rights Issue
• Preferential Issue
• Qualified Institutions Placement (QIP)

Due to the absence of such fund-raising activities, the company stated that the Statement of Deviation or Variation requirement is not applicable.

Company Information

The communication includes standard corporate details with the company's registered office located at 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054. The filing was digitally signed by Company Secretary & Compliance Officer Chaitra Arora on 14th April, 2026, at 15:38:55 +05'30'.

This regulatory filing demonstrates the company's commitment to maintaining transparency and compliance with SEBI's disclosure requirements, even when specific regulations are not applicable to their current business activities.